Articles from Caixin Global, Caixin Global

Caixin Global

Articles from Caixin Global

Caixin is a media group dedicated to providing financial and business news through periodicals, online content, mobile apps, conferences, books and TV/video programs. Caixin aims to blaze a trail that helps traditional media prosper in the new media age through integrated multimedia platforms.

News from Caixin

Cross Asset Strategy

<ul><li>Cover Story: Where Covid vaccine development is going</li><li>Hong Kong’s new chief executive pledges to review IPO rules to attract foreign firms</li><li>Knife-wielding attacker injures five people at Shanghai hospital</li></ul>

Cover Story: Where Covid vaccine development is goingHong Kong’s new chief executive pledges to review IPO rules to attract foreign firmsKnife-wielding attacker injures five people at Shanghai hospital

CX Daily: Where Covid Vaccine Development Is Going

China

Brii Biosciences operates as a biotechnology company. The Company discovers and develops therapeutics and medicines for the treatment of diseases. Brii Biosciences serves customers in the United States and China.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Brii Biosciences (2137 HK)

CX Daily: Where Covid Vaccine Development Is Going

Cover Story: Where Covid vaccine development is going. Hong Kong’s new chief executive pledges to review IPO rules to attract foreign firms

Caixin Global

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)